Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Vote In favor of Your Favored Pizza Cover - 2The Excursion to Monetary Proficiency: Individual budget Triumphs
- 3There was a bit of toilet trouble on NASA's Artemis 2 mission to the moon
- 4NASA’s Artemis II mission will take an astronaut crew around the Moon – a space policy expert describes the long road to launch
- 5The EU Is Considering Lifting Tariffs on Chinese Electric Vehicles
- 4 Excellent Remote Headphones of 2024
- Top 15 Style Creators Changing the Business
- San Francisco mayor says city in talks to bring pandas back to zoo ahead of trip to Asia
- Whale stranded off Germany for days is stuck again
- Syrian army says recent drone attacks targeted its bases near Iraq, most shot down
- SpaceX launches Starlink missions in dual-coast spaceflight doubleheader (videos)
- What's inside Mexico's Popocatépetl? Scientists obtain first 3D images of the whole volcano
- 6 Web-based Course Stages for Successful Learning and Educating
- How to watch ‘The Traitors’ U.K. Season 4 premiere today from the U.S.
